Skip to main content
. 2024 Dec 12;36(4):408–419. doi: 10.37616/2212-5043.1398

Table 1.

Demographic and clinical data of the studied patients.

All patients
N = 71
Groups P value

Group 1.1 and 1.2
N = 39
Group 1.4.4
N = 27
Group 5
N = 5
Age
Minimum–maximum 5.00–228.00 12.00–228.00 5.00–216.00 24.00–144.00 0.75
Mean – SD 91.04 ± 52.34 86.97 ± 47.68 99.11 ± 59.58 79.20 ± 49.91
Median 84.00 84.00 84.00 84.00
IQR 54.00 to 130.50 46.50 to 120.00 54.50 to 162.00 33.00 to 117.00
Gender No. % No. % No. % No. %
Male 29 40.8 17 43.6 10 37 2 40 0.87
Female 42 59.2 22 56.4 17 63 3 60
Height
Minimum–maximum 62.00–159.00 74.00–159.00 62.00–147.00 81.00–130.00 0.78
Mean – SD 115.21 ± 22.94 116.35 ± 22.97 113.92 ± 23.75 113.00 ± 22.43
Median 117.00 119.00 110.00 120.50
IQR 97.50 to 132.00 100.00 to 132.00 95.00 to 140.00 97.50 to 128.50
Weight
Minimum–maximum 4.50–60.00 8.00–60.00 4.50–45.00 6.50–33.00 0.88
Mean – SD 22.47 ± 11.88 22.72 ± 12.74 22.57 ± 11.04 19.90 ± 11.15
Median 20.00 20.00 22.00 21.00
IQR 13.00 to 29.50 13.25 to 27.25 13.00 to 30.00 9.87 to 29.25
Syncope No. % No. % No. % No. %
No syncope 58 81.7 26 66.7 27 100 5 100 a0.0015
Syncope 13 19.3 13 33.3 0 0 0 0
Cyanosis No. % No. % No. % No. %
No cyanosis 54 76.1 37 94.9 12 44.4 5 100 a<0.0001
Cyanosis 17 23.9 2 5.1 15 55.6 0 0
Dyspnea No. % No. % No. % No. %
No Dyspnea 6 8.5 3 8 3 11.1 0 0 0.69
Dyspnea 65 91.5 36 92.3 24 88.9 5 100
WHO FC No. % No. % No. % No. %
WHO FC 1 8 11.3 5 12.8 3 11.1 0 0 0.06
WHO FC 2 39 54.9 16 41 21 77.8 2 40
WHO FC 3 14 19.7 11 28.2 1 3.7 2 40
WHO FC 4 10 14.1 7 18 2 7.4 1 20
O 2 Sat
Minimum–maximum 0.65–1.00 0.70–1.00 0.65–0.99 0.88–0.96 a0.000159
Mean – SD 0.92 ± 0.075 0.94 ± 0.06 0.88 ± 0.08 0.93 ± 0.038
Median 0.94 0.96 0.89 0.94
IQR 0.88 to 0.97 0.94 to 0.98 0.86 to 0.91 0.89 to 0.96
Clubbing No. % No. % No. % No. %
No clubbing 57 80.3 37 94.8 16 59.3 4 80 a0.0055
Grade 1 6 6 2 5.1 4 14.8 0 0
Grade 2 8 11.3 0 0.0 7 25.9 1 20
RV failure No. % No. % No. % No. %
No RV failure 48 67.6 24 61.5 23 85.2 1 20 *0.0081
RV failure 23 32.4 15 38.5 4 14.8 4 80
6MWD
Minimum–maximum 40.00–540.00 40.00–450.00 60.00–540.00 100.00–418.00 0.17
Mean – SD 273.32 ± 139.99 242.73 ± 136.38 316.80 ± 137.05 289.33 ± 167.45
Median 300.00 256.00 355.00 350.00
IQR 150.00 to 390.00 100.00 to 380.00 180.00 to 413.00 162.50 to 401.00
6MWD (age adjusted)
Minimum–maximum −10.00–0.50 −10.00–0.50 −10.00–−0.40 −9.56–−2.40 0.33
Mean – SD −4.89 ± 2.72 −5.31 ± 2.65 −4.17 ± 2.70 −5.45 ± 3.69
Median −4.88 −5.38 −4.11 −4.40
IQR −6.84 to −2.86 −7.25 to −2.98 −4.93 to −2.21 −8.27 to −2.90
6MWD (height adjusted)
Minimum–maximum −9.50–1.48 −9.28–1.00 −9.50–1.48 −7.90–−2.70 0.40
Mean – SD −4.20 ± 2.53 −4.57 ± 2.40 −3.59 ± 2.69 −4.52 ± 2.92
Median −3.59 −4.41 −3.09 −2.98
IQR −5.92 to −2.68 −6.35 to −2.69 −4.17 to −2.57 −6.67 to −2.77
NT Pro-BNP
Minimum–maximum 20.00–15000.00 20.00–15000.00 25.20–15000.00 479.80–5019.00 0.58
Mean – SD 3553.79 ± 4101.02 4101.82 ± 4140.68 3107.19 ± 4305.48 1910.12 ± 1900.59
Median 1982.00 2405.40 1234.10 1033.00
IQR 373.92 to 5472.00 304.37 to 6160.40 368.37 to 4423.47 571.30 to 3067.50
NT Pro-BNP z score
Minimum–maximum −1.48–6.99 −1.48–6.23 −0.69–6.99 2.51–5.18 0.51
Mean – SD 3.57 ± 1.91 3.69 ± 2.09 3.42 ± 1.82 3.50 ± 1.08
Median 3.94 4.39 3.33 3.00
IQR 2.42 to 5.07 1.84 to 5.38 2.60 to 4.76 2.77 to 4.25
Outcome No. % No. % No. % No. %
Morbidity 16 22.5 8 20.5 5 18.5 3 60 0.32
Mortality 17 23.9 10 25.6 6 22.2 1 20

p: p value for comparing between the different studied groups.

*

Statistically significant at p ≤ 0.05.